Sapanisertib

TargetMol
Product Code: TAR-T1838
Supplier: TargetMol
CodeSizePrice
TAR-T1838-1mg1mg£98.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-2mg2mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-5mg5mg£132.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-1mL1 mL * 10 mM (in DMSO)£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-10mg10mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-25mg25mg£201.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-50mg50mg£269.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-100mg100mg£367.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1838-500mg500mg£780.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
INK 128 is an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity.
CAS:
1224844-38-5
Formula:
C15H15N7O
Molecular Weight:
309.333
Pathway:
PI3K/Akt/mTOR signaling; Autophagy
Purity:
0.9934
SMILES:
CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc12
Target:
PI3K; mTOR; Autophagy

References

1. Liu A, et al. Drug Discovery Today: Therapeutic Strategies. 2009, 6(2), 47-55. 2. Jessen K, et al. Mol Cancer Ther. 2009, 8(12), Meeting Abstract Supplement. 3. Hsieh AC, et al. Nature. 2012, 485(7396), 55-61. 4. Zhao, Ming, et al. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein. Nature Communications . 12.1 (2021): 1-14.